Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis.
D000818:Animals; D002908:Chronic Disease; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D005260:Female; D005620:Freund's Adjuvant / Q000627:therapeutic use; D005699:Galactosylceramides / Q000627:therapeutic use; D006168:Guinea Pigs; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D004676:Myelin Basic Protein / Q000627:therapeutic use; D009186:Myelin Sheath / Q000276:immunology / Q000473:pathology; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D012008:Recurrence; D013116:Spinal Cord / Q000276:immunology / Q000473:pathology
D005699:Galactosylceramides; D004676:Myelin Basic Protein; D005620:Freund's Adjuvant